Disposition of Carbamazepine and Phenytoin in Pregnancy
- 1 January 1994
- Vol. 35 (1), 131-135
- https://doi.org/10.1111/j.1528-1157.1994.tb02922.x
Abstract
Free and total plasma concentrations of phenytoin (PHT) and carbamazepine (CBZ) and its active metabolite carbamazepine-10, 11-epoxide (CBZ-E) were determined in a prospective study of 86 pregnant epileptic women. The pharmacokinetics of PHT and CBZ during the three trimesters were compared with kinetics at least 10 weeks postpartum. Plasma clearance and unbound CBZ clearance were slightly decreased during the last trimester. Total and free plasma CBZ-E concentrations did not change significantly during pregnancy. Plasma PHT clearance, on the other hand, increased from the first trimester. A less pronounced increase was observed for clearance of unbound PHT; the increase was statistically significant only during the third trimester.Keywords
This publication has 14 references indexed in Scilit:
- Plasma Antiepileptic Drug Concentrations During PregnancyEpilepsia, 1991
- The effect of pregnancy in humans on the pharmacokinetics of stable isotope labelled phenytoin.British Journal of Clinical Pharmacology, 1989
- The course of epilepsy during pregnancy: a study of 78 casesActa Neurologica Scandinavica, 1988
- Clinical Pharmacokinetics and Pharmacological Effects of Carbamazepine and Carbamazepine-10,11-EpoxideClinical Pharmacokinetics, 1986
- Effects of Pregnancy on Antiepileptic Drug UtilizationEpilepsia, 1985
- Teratogenicity of Antiepileptic Drug Combinations with Special Emphasis on Epoxidation (of Carbamazepine)Epilepsia, 1984
- Serum protein binding and free concentration of phenytoin and phenobarbitone in pregnancy.British Journal of Clinical Pharmacology, 1982
- The Epileptic Mother and Her ChildEpilepsia, 1982
- Anticonvulsants during Pregnancy and LactationClinical Pharmacokinetics, 1982
- Plasma Protein Binding of Drugs in PregnancyClinical Pharmacokinetics, 1982